hyperplasia of mammary glands
Conditions
Interventions
Placebo patch group:Placebo patch,apply it to the upper quadrant of the painful breast, 1 week before menstruation, once a day, 20min each time
Placebo hot compress cream group,:Placebo patch and External heating package,apply it to the upper quadrant of the painful breast, 1 week before menstruation, once a day, 20min each time
WuZi hot compress cream group:WuZi hot compress cream group,apply it to the upper quadrant of the painful breast, 1 week before menstruation, once a day, 20min each time
Sponsors
Yueyang Integrated Traditional Chinese and Western Medicine Hospital affiliated with Shanghai University of Traditional Chinese Medicine
Eligibility
Sex/Gender
Female
Age
20 Years to 50 Years
Inclusion criteria
Inclusion criteria: (1) Premenopausal women aged 20-50 years old; (2) Meets the Western medical diagnostic criteria for breast hyperplasia breast pain; (3) Meets the diagnostic criteria for liver depression and phlegm coagulation syndrome in breast hyperplasia; (4) Voluntary participants in this study, informed consent and signing of informed consent form.
Exclusion criteria
Exclusion criteria: (1) Patients with combined breast inflammation, breast malignant tumors, or other breast diseases with surgical indications; (2) Having severe primary diseases such as cardiovascular, cerebrovascular, liver, kidney, and hematopoietic systems; (3) Those who have received relevant treatment for breast hyperplasia within 3 months before the treatment (including oral, topical drugs, acupuncture and moxibustion, etc.), and those who have used hormone preparations, oral contraceptives, and hormone replacement therapy drugs in the past six months; (4) Individuals with skin trauma, ulcers, skin infections, or scarring in the application area, as well as those who are allergic to the patch; (5) Partial/complete removal of ovaries or uterus; (6) Cognitive impairment, difficulty understanding the content of the scale and completing self-assessment of the scale; (7) Pregnant or lactating women or those who have planned pregnancy in the past three months; (8) Participants in other clinical trials during the same period.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Total effective rate at the end of treatment; | — |
Secondary
| Measure | Time frame |
|---|---|
| Hospital Anxiety and Depression Scale, HADS;TCM syndrome efficacy score; | — |
Countries
China
Contacts
Public ContactJiang Ke
Yueyang Integrated Traditional Chinese and Western Medicine Hospital affiliated with Shanghai University of Traditional Chinese Medicine
Outcome results
None listed